Literature DB >> 4791304

Tobramycin concentrations during peritoneal dialysis.

A J Weinstein, A W Karchmer, R C Moellering.   

Abstract

A patient undergoing peritoneal dialysis for severe renal failure was treated with tobramycin. Peritoneal dialysis was inefficient in removing tobramycin from the serum. Tobramycin concentrations in the dialysis effluent were low. Despite acute oliguric renal failure, urine concentrations of tobramycin were sufficient to treat most gram-negative urinary tract infections.

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4791304      PMCID： PMC444572          DOI： 10.1128/AAC.4.4.432

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  7 in total

1.  GENTAMICIN: ACTIVITY IN VITRO AND OBSERVATIONS IN 26 PATIENTS.

Authors:  J O KLEIN; T C EICKHOFF; M FINLAND
Journal:  Am J Med Sci       Date:  1964-11       Impact factor: 2.378

2.  Preclinical assessment of the antibacterial activity of nebramycin factor 6.

Authors:  D A Preston; W E Wick
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

3.  Correlation of serum creatinine concentration and gentamicin half-life.

Authors:  R E Cutler; A M Gyselynck; W P Fleet; A W Forrey
Journal:  JAMA       Date:  1972-02-21       Impact factor: 56.272

4.  Preliminary studies with nebramycin factor 6.

Authors:  H R Black; R S Griffith
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

5.  Tobramycin: in vitro activity and comparison with kanamycin and gentamicin.

Authors:  V E Del Bene; W E Farrar
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

6.  In vitro studies of tobramycin, an aminoglycoside antibiotic.

Authors:  J Dienstag; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1972-01       Impact factor: 5.191

7.  Tobramycin and gentamicin concentrations in the serum of normal and anephric patients.

Authors:  W R Lockwood; J D Bower
Journal:  Antimicrob Agents Chemother       Date:  1973-01       Impact factor: 5.191
  7 in total
  4 in total

1.  Antibiotic penetrance of ascitic fluid in dogs.

Authors:  D N Gerding; J P Kromhout; J J Sullivan; W H Hall
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

2.  Pharmacokinetics of tobramycin in patients with stable renal impairment, patients undergoing peritoneal dialysis, and patients on chronic hemodialysis.

Authors:  G Jaffe; B R Meyers; S Z Hirschman
Journal:  Antimicrob Agents Chemother       Date:  1974-06       Impact factor: 5.191

3.  Effect of peritoneal dialysis on serum levels of tobramycin and clindamycin.

Authors:  R F Malacoff; F O Finkelstein; V T Andriole
Journal:  Antimicrob Agents Chemother       Date:  1975-11       Impact factor: 5.191

Review 4.  Tobramycin: a review of its antibacterial and pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; R M Pinder; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.